| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Officer
2 companies
Sara N Ortwein is Executive Officer at XOM, with reported holdings spanning 2 companies. Sara N Ortwein's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $53.2M at current prices.
Sara N Ortwein's largest disclosed position is in XOM as Executive Officer, worth about $52.3M. The XOM filings lean toward selling, a net 5,000 shares.
Sara N Ortwein has 14 Form 4 filings on record from November 2016 to June 2026, across 2 companies: Director at Sanara MedTech (SMTI), 2022–2026; Executive Officer at Exxon Mobil (XOM), 2016–2018.
The 17 reported transactions were 10 stock awards, 4 tax withholdings, 2 gifts and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $454K.
The only open-market sale was 5,000 shares of XOM at an average $90.88 on December 15, 2016, about $454K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2016 | XOM Exxon Mobil Corp | Executive Officer | Sell | 5,000 | $90.88 | $454,384.00 | -2.2% |